sabatolimab
Novartis
['fil,veral,12', 'myeloid', 'mds', 'adaptive ']
 sabatolimab+hypomethylating agents in adult patients with high risk is associated with a safety profile compared to placebo #mds #ash22 #mdssm 
Our nonprofit empowers patients with Myelodysplastic Syndromes through each step of their journey - diagnosis, education, care and on to a cure!